Friday, July 23, 2010

Eisai and Pfizer Announce FDA Approval for New Higher-Dose Aricept Tablet for the Treatment of Moderate to Severe

Specific to moderate to severe Alzheimer's disease.
Eisai Inc. and Pfizer Inc [NYSE: PFE] announced today that the U.S. Food and Drug Administration (FDA) approved a new once-daily, higher-dose Aricept (donepezil HCl) 23 mg tablet for the treatment of moderate-to-severe Alzheimer’s disease (AD). Aricept 23 mg tablet offers another dosing option for patients with moderate-to-severe AD, for whom few treatments are available.
Original content Bob DeMarco, the Alzheimer's Reading Room
 blog it

Tuesday, July 13, 2010

Learning Never Ends

This is a great lesson for all of us today, as we face our own hard times. Joe never remembered our names, but he knew that we appreciated the life lessons that he shared with us....
We work with people living with Alzheimer’s in all sorts of settings, and in every one of these settings we find people who are still curious, still able to learn.
Original content Tom and Karen Brenner, the Alzheimer's Reading Room
 blog it

Sunday, July 11, 2010

Vitamin D Deficiency Increases Risk of Cognitive Impairment

It is now becoming known that for those over 60 years of age Vitamin deficiency is a major health problem.
David Llewellyn, PhD, of the University of Exeter Peninsula Medical School (UK), and colleagues examined information from 3,325 adults aged 65 years and older from the Third National Health and Nutrition Examination Survey (NHANES III), a study that was carefully designed to accurately represent the U.S. non-institutionalized population. Vitamin D levels were measured from blood samples and compared with performance on a measure of general cognitive function that incorporated tests of memory, orientation in time and space, and ability to maintain attention.
Original content Bob DeMarco, the Alzheimer's Reading Room
 blog it

Four Researchers Given Lifetime Achievement Awards By the Alzheimer's Association

The Alzheimer's Association recognized four scientists for their extraordinary achievements in advancing Alzheimer research at the Alzheimer's Association International Conference on Alzheimer's Disease 2010 (AAICAD 2010) in Honolulu, Hawaii.
Honorees for their professional and scientific contributions to Alzheimer research are:
  • Takeshi Iwatsubo, MD, Department of Neuropathology, Graduate School of Medicine at the University of Tokyo.

  • Karen H. Ashe, MD, PhD, Department of Neurology and Neuroscience Director at the University of Minnesota.

  • Marsel Mesulam, MD, Dunbar Professor of Neurology and Psychiatry and Director of the Cognitive Neurology and Alzheimer's Disease Center at Northwestern University.

  • Marilyn Albert, PhD, Director of the Division of Cognitive Neuroscience in the Department of Neurology at Johns Hopkins University School of Medicine.

Original content Bob DeMarco, the Alzheimer's Reading Room
 blog it

Saturday, July 03, 2010

Alzheimer's Caregiver Lament -- This is Not the Person I Knew (Audio)

By Bob DeMarco
Alzheimer's Reading Room

In order to communicate effectively with a person suffering from Alzheimer's disease you need to come to an understanding that they are now living in a new world -- I often refer to this as Alzheimer's world....